Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Infectious diseases

Antibodies from Zika patient protect mice against disease

A study demonstrates the promise of antibody-based immunotherapy against Zika virus, without cross-reactivity against Dengue virus.

Micrograph of Zika virus particles

Source: CDC / Cynthia Goldsmith

Researchers isolated Zika-specific monoclonal antibodies from the blood of a recuperating patient (Zika virus particles pictured)

Attempts to isolate human monoclonal antibodies (mAbs) against Zika virus have led to broadly neutralising antibodies that also show activity against Dengue virus. If used therapeutically, this “cross-reactivity” could potentially increase the severity of Dengue fever if a patient subsequently caught Dengue virus.

To address this situation, researchers attempted to isolate Zika-specific mAbs from the blood of a recuperating patient.

They identified two mAbs that potently bound and neutralised Zika virus in vitro, but did not show any activity against the four known strains of Dengue virus. Mice infected with Zika virus were completely protected when either mAb was administered one day after infection.

Reporting in Science Translational Medicine[1] (online, 14 December 2016), the team says the results show the promise of antibody-based immunotherapy against Zika virus, and provide a basis for the design of future Zika-specific antivirals.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202257

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmacy Case Studies

    Pharmacy Case Studies

    Understand the application of therapeutics in clinical practice with Pharmacy Case Studies. This book helps you to demonstrate the knowledge gained during your studies.

    £32.00Buy now
  • Disease Management

    Disease Management

    Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.

    £52.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £37.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £37.00Buy now
  • Integrated Pharmacy Case Studies

    Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

    £42.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £42.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Micrograph of Zika virus particles

Jobs you might like

See more jobs

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.